Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Total Liabilities: 2019-2025

Historic Total Liabilities for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $90.4 million.

  • Biodesix's Total Liabilities rose 20.78% to $90.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.4 million, marking a year-over-year increase of 20.78%. This contributed to the annual value of $76.4 million for FY2024, which is 19.20% down from last year.
  • Latest data reveals that Biodesix reported Total Liabilities of $90.4 million as of Q3 2025, which was up 4.44% from $86.6 million recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Total Liabilities peaked at $94.5 million during Q4 2023, and registered a low of $53.9 million during Q1 2022.
  • Moreover, its 3-year median value for Total Liabilities was $84.6 million (2023), whereas its average is $83.6 million.
  • Per our database at Business Quant, Biodesix's Total Liabilities tumbled by 31.86% in 2022 and then surged by 41.53% in 2023.
  • Biodesix's Total Liabilities (Quarterly) stood at $56.4 million in 2021, then rose by 28.26% to $72.3 million in 2022, then spiked by 30.73% to $94.5 million in 2023, then decreased by 19.20% to $76.4 million in 2024, then grew by 20.78% to $90.4 million in 2025.
  • Its last three reported values are $90.4 million in Q3 2025, $86.6 million for Q2 2025, and $75.2 million during Q1 2025.